AbbVie’s Q4 results beat expectations


AbbVie (NYSE: ABBV) topped revenue and earnings expectations for the fourth quarter of 2019, allowing the stock to gain over 3% in premarket hours on Friday.

Net revenues of $8.70 billion was up 4.8% compared to the
same period a year ago and ahead of consensus estimates of $8.69 billion.  

On a GAAP basis, the company reported net earnings of $2.8
billion, or $1.88 per share, compared to a net loss of $1.8 billion, or $1.23 per
share, last year. Adjusted EPS totaled $2.21, beating forecasts of $2.19.   

For the full year of 2020, the company expects GAAP EPS to
be $7.66-7.76 and adjusted EPS to be $9.61-9.71.

(This story will be updated shortly)